[一般演題15] Liver 3

[O-119] Cost analysis of HAIC versus sorafenib for locally advanced HCC

^○KEI SHIBUYA¹, HIROYUKI TOKUE¹, MASAYA MIYAZAKI¹, HIROKI TOJIMA², YUICHI YAMAZAKI², SATORU KAKIZAKI² (1.Department of Diagnostic and Interventional Radiology, Gunma University Hospital, Maebashi, Japan, 2.Department of Gastroenterology and Hepatology, Gunma University Hospital, Maebashi, Japan)